Malin Bornschein joins Reccan as new CEO

We are welcoming our new CEO Malin Bornschein!

Malin has 15 years of experience from development, production, commercialisation, and distribution within life science. Using her experience of leading life science companies through change, she is eager to participate in taking Reccan to the next level. Most recently Malin headed the Scandinavian office of the world leading health care distributor Henry Schein. Previous assignments include responsibility for operations, contract manufacturing, marketing and business development at SVAR Lifescience, Dako/Agilent and Alcimed. Malin has (in addition to Sweden) been located in Denmark, France and Germany and worked with partners, customers and colleagues globally.

 In addition to a MSc degree in Engineering Biology from LiTH (Linköping, Sweden), Malin holds a PhD in Genetics from Ruhr University (Bochum, Germany) as well as a BSc in Business Administration from the Linnæus University (Växjö, Sweden).

"It is such an honour to be part of Reccan’s continued development together with amazing, experienced colleagues and Board of Directors. I am highly motivated to our common endeavour to advance diagnosis of pancreatic cancer with blood test development, saving lives through early detection.”

- Malin Bornschein